News & Events

Guest Feature: “Yes, and…” by Catherine Savini

Navigating the symptoms of FTD can be difficult for loved ones, especially when someone living with the disease experiences memory-related challenges. However, as Catherine Savini shares, meeting symptoms with “yes, and” instead…

MORE

When One Voice Sounds Like a Chorus: Dawn Kirby’s Relentless Campaign to Raise FTD Awareness

Dawn Kirby and her husband, Tim, are getting the word out about FTD. The couple were recently featured in an article in the Prairie Press (Paris, Ill.), where they talked…

MORE

AFTD Volunteer Secures 3 FTD Awareness Week Proclamations in Ohio

Lima, Ohio is the most recent community to officially proclaim September 22-29 as FTD Awareness Week. Resident Jack George successfully advocated for the official proclamation, which Lima Mayor Sharetta Smith…

MORE

Advancing Hope: AFTD Hosts Industry Advisory Panel

On August 8 and 9, AFTD hosted an industry advisory panel in which a group of people whose lives have been touched by FTD shared their experiences and perspectives with…

MORE

Guest Feature: One Woman’s Journey – from Getting Diagnosed to Attempting Suicide to Embracing Life

September is Suicide Prevention Month. Below, Deb Jobe, a member of AFTD’s Persons with FTD Advisory Council, courageously shares the story of her suicide attempt following an FTD diagnosis, and…

MORE

Medical Technology CEO Discusses Using EEG to Differentiate FTD and Alzheimer’s

In an interview with Neurology Live, Advanced Brain Monitoring CEO Chris Berka shares insights from a pilot study that found how electroencephalography (EEG) can be used to differentiate between FTD,…

MORE

A Conversation with Juan Chavez, MD, of Passage Bio

AFTD recently spoke with Passage Bio Vice President of Clinical Development Juan Chavez, MD, about the company’s work to develop a therapy addressing FTD. Here, Dr. Chavez shares where he…

MORE

Acurastem Receives CIRM Grant for Targeted Therapeutic Program for ALS/FTD

Biotechnology company AcuraStem announced that it has received a $4 million grant from the California Institute for Regenerative Medicine (CIRM) for its targeted therapeutic program for ALS and FTD. The…

MORE